ConductScience.org, home

Paper41745765

Cross-Induction of Anti-Complexing Antibodies in Patients Treated with Botulinum Toxin Formulations Containing Complexing Proteins.

Srinoulprasert Y and 6 others. Toxins (Basel), 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Cross-Induction of Anti-Complexing Antibodies in Patients Treated with Botulinum Toxin Formulations Containing Complexing Proteins. Papers, record 41745765. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41745765

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Cross-Induction of Anti-Complexing Antibodies in Patients Treated with Botulinum Toxin Formulations Containing Complexing Proteins.
PubMed
Journal
Toxins (Basel)
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-08-13
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Srinoulprasert YYuttanahttps://orcid.org/0000-0003-3004-5771
2Sirisuthivoranunt SSurachet
3Sripatumtong CChattip
4Tansit TTunsuda
5Yamlexnoi PPornsuk
6Meethong OOnjira
7Wanitphakdeedecha RRungsimahttps://orcid.org/0000-0002-3926-2193

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
N/AMahidol UniversityPubMed

Source PubMed

Download CSV of grants

References24

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
115201348Botulinum toxin in clinical practice.J Neurol Neurosurg Psychiatry2004https://conductscience.org/library/papers/15201348PubMed
221209727Complexing proteins in botulinum toxin type A drugs: a help or a hindrance?Biologics2010https://conductscience.org/library/papers/21209727PubMed
330013379Comparison of botulinum neurotoxin type A formulations in Asia.Clin Cosmet Investig Dermatol2018https://conductscience.org/library/papers/30013379PubMed
420418969Botulinum toxin.Indian J Dermatol2010https://conductscience.org/library/papers/20418969PubMed
536445847Botulinum toxin for cosmetic treatments in young adults: An evidence-based review and survey on current practice among aesthetic practitioners.J Cosmet Dermatol2023https://conductscience.org/library/papers/36445847PubMed
640729416Systematic Review and Meta-Analysis of Secondary Treatment Failure and Immunogenicity With Botulinum Neurotoxin A in Multiple Indications.Eur J Neurol2025https://conductscience.org/library/papers/40729416PubMed
736923693A Preclinical Study Comparing the Activity and Potency of OnabotulinumtoxinA and PrabotulinumtoxinA.Clin Cosmet Investig Dermatol2023https://conductscience.org/library/papers/36923693PubMed
832445175Association Between Secondary Botulinum Toxin A Treatment Failure in Cosmetic Indication and Anti-Complexing Protein Antibody Production.Dermatol Ther (Heidelb)2020https://conductscience.org/library/papers/32445175PubMed
940526262Diffusion Characteristics of LetibotulinumtoxinA, OnabotulinumtoxinA, and AbobotulinumtoxinA and its Impact on Muscle Relaxation: A Randomized Split-Face Clinical Trial.Dermatol Ther (Heidelb)2025https://conductscience.org/library/papers/40526262PubMed
1024250334Efficacy of Onabotulinum Toxin A (Botox) versus Abobotulinum Toxin A (Dysport) Using a Conversion Factor (1 : 2.5) in Treatment of Primary Palmar Hyperhidrosis.Dermatol Res Pract2013https://conductscience.org/library/papers/24250334PubMed
1130893162Efficacy and Safety of PrabotulinumtoxinA for the Treatment of Glabellar Lines in Adult Subjects: Results From 2 Identical Phase III Studies.Dermatol Surg2019https://conductscience.org/library/papers/30893162PubMed
1235086302Immunogenicity of botulinum toxin.Arch Plast Surg2022https://conductscience.org/library/papers/35086302PubMed
1338393178Complexing Protein-Free Botulinum Neurotoxin A Formulations: Implications of Excipients for Immunogenicity.Toxins (Basel)2024https://conductscience.org/library/papers/38393178PubMed
1436136523Safety Profile and Lack of Immunogenicity of IncobotulinumtoxinA in Pediatric Spasticity and Sialorrhea: A Pooled Analysis.Toxins (Basel)2022https://conductscience.org/library/papers/36136523PubMed
1530551641AbobotulinumtoxinA (Dysport®), OnabotulinumtoxinA (Botox®), and IncobotulinumtoxinA (Xeomin®) Neurotoxin Content and Potential Implications for Duration of Response in Patients.Toxins (Basel)2018https://conductscience.org/library/papers/30551641PubMed
1628356439Botulinum Neurotoxins: Biology, Pharmacology, and Toxicology.Pharmacol Rev2017https://conductscience.org/library/papers/28356439PubMed
1717928429Antibody detection and kinetics of antibody production during early stages of immunization with hepatitis B virus vaccine.Clin Vaccine Immunol2007https://conductscience.org/library/papers/17928429PubMed
1835333944Toxicology and pharmacology of botulinum and tetanus neurotoxins: an update.Arch Toxicol2022https://conductscience.org/library/papers/35333944PubMed
1940911274A Pilot Study of Differences in Antibody Responses of Intradermal and Intramuscular Injections of Botulinum Toxin Type A.Dermatol Ther (Heidelb)2025https://conductscience.org/library/papers/40911274PubMed
2030681794IncobotulinumtoxinA: A Highly Purified and Precisely Manufactured Botulinum Neurotoxin Type AJ Drugs Dermatol2019https://conductscience.org/library/papers/30681794PubMed

See all 24 referencesDownload CSV of references

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ALB213PubTator's text mininghttps://conductscience.org/library/genes/213NCBI Gene
CP1356PubTator's text mininghttps://conductscience.org/library/genes/1356NCBI Gene
SNAP256616PubTator's text mininghttps://conductscience.org/library/genes/6616NCBI Gene
TLR27097PubTator's text mininghttps://conductscience.org/library/genes/7097NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Cited by
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41745765

GET https://conductscience.org/api/papers/v1/41745765/references?page=2